Amphastar Pharmaceuticals Inc vs Invesco WilderHill Clean Energy ETF — how do they compare? Amphastar Pharmaceuticals Inc trades at $19.38 (market cap $826.08M), while Invesco WilderHill Clean Energy ETF trades at $34. The key difference: Invesco WilderHill Clean Energy ETF is trading nearer its 52-week high, Amphastar Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| AMPH | PBW | |
|---|---|---|
Market Cap | $826.08M | — |
Sector | Health | Sector/Thematic |
52-Week High | $30.81 | $46.99 |
52-Week Low | $16.87 | $22.11 |
Enterprise Value | $1.22B | — |
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $18.72, down 1.58% on the day, with a bearish technical signal from moving averages. Recent earnings missed estimates in Q1 2026, with revenue of $171.2 million and adjusted EPS of $0.42 versus $0.70 expected. The company is shifting focus toward proprietary drugs and biosimilars for growth, as noted at recent investor conferences.
Outlook is mixed: valuation ratios appear reasonable with P/E of 11.29 and EV/EBITDA of 6.32, but earnings misses and a Zacks Strong Sell rating highlight near-term risks. The consensus price target of $20.40 suggests modest upside if execution improves, though legal scrutiny and competitive pressures remain concerns.
No Aura AI signal available yet.
Trailing returns across standard periods
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →PBW is an equal-weighted ETF that invests in U.S. companies leading the clean energy transition. It focuses on renewable energy, power conservation, and sustainable technologies like solar, wind, and energy storage.
Read more on PBW →